Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 August 2018 Photo Barend Nagel
WomenOfKovsies Dr Hoppener research affects access of rural youth to university
Dr Mikateko Höppener is also the author of a book titled, Engineering Education for Sustainable Development: A Capabilities Approach, which is based on her PhD research.

Since September 2016, Dr Mikateko Höppener and a team of researchers have been engaged in a four-year long investigation of the multidimensional factors and dynamics that influence low-income learners’ opportunities to access, participate, and succeed in higher education.

Dr Höppener is a Senior Researcher at the university, working under the leadership of Prof Melanie Walker, South African Research Chairs Initiative (SARChI) Chair and Director of the Higher Education and Human Development Research Programme.

Women in academia

Dr Höppener is part of a team comprised of women whom she constantly learns from and who inspire appreciation.. “I am filled with gratitude for being in the position I am in as a young woman. I have the privilege of working with a team of very inspirational, motivating and encouraging women. The Miratho Project is led by a woman and the rest of the team members are also women,” she says.

Access to higher education
The Miratho Project is undertaken in collaboration with Thusanani Foundation, a youth-led, nonprofit organisation. It is funded by the Economic and Social Research Council, and the UK’s Department for International Development. Rural and township learners from low-income backgrounds are the subject of this multimethod, longitudinal study which tracks their progress into higher education and through to employment.

Among its key objectives, Miratho aims to develop a multidimensional learning outcomes index as an instrument of public debate and guiding government policy. As such it contributes to transforming and decolonising higher education.  

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept